NEW YORK, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Cayson Acquisition Corp (NASDAQ:CAPNU) (the “Company”) announced today that, commencing on or about October 24, 2024, holders of its units sold in the...
NEW YORK, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Cayson Acquisition Corp (the “Company”) announced today that it priced its initial public offering of 6,000,000 units at $10.00 per unit. The...
REDWOOD CITY, Calif., July 24, 2017 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (NASDAQ:SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of...
Positive guidance received on key elements of Phase III programCompany expects to initiate pivotal Phase III clinical trial by year-end 2017DCCR has orphan designation for the treatment of PWS...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.0018 | -0.018018018018 | 9.99 | 9.99 | 9.98 | 7309 | 9.98600716 | CS |
4 | -0.1518 | -1.49704142012 | 10.14 | 10.14 | 9.97 | 12543 | 9.99015626 | CS |
12 | 9.2882 | 1326.88571429 | 0.7 | 10.14 | 0.7 | 20432 | 9.97139498 | CS |
26 | 9.2882 | 1326.88571429 | 0.7 | 10.14 | 0.7 | 9492 | 9.97139498 | CS |
52 | 9.2882 | 1326.88571429 | 0.7 | 10.14 | 0.7 | 4784 | 9.97139498 | CS |
156 | 9.2882 | 1326.88571429 | 0.7 | 10.14 | 0.7 | 1601 | 9.97139498 | CS |
260 | 9.2882 | 1326.88571429 | 0.7 | 10.14 | 0.7 | 1149 | 9.97139498 | CS |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales